FDA inspection

Recipharm Leganes SLU: FDA inspection ending Oct 26, 2023

FDA inspection 1261202 · Voluntary Action Indicated (VAI) · Leganes

Key facts

Inspection ID 1261202
Firm Recipharm Leganes SLU
FEI number 3000298591
Address Calle De Severo Ochoa 13
City Leganes
Country Spain
Fiscal year 2024
Inspection end date Oct 26, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections